338. David Hysong, Founder & CEO Of SHEPHERD Health, Is Offering New Solutions & Treatments For Rare Cancers, Leveraging The Power Of RNA & AI

David Hysong is the CEO and Founder of SHEPHERD Health. When David was diagnosed with a rare form of head and neck cancer called adenoid cystic carcinoma at 27, he dedicated his life to finding cures for rare cancers and SHEPHERD Health was born. During our conversation,  David and I sync up about the idea and inspiration behind SHEPHERD Health, how the company is leveraging the power of AI, SHEPERD’s  proprietary platform DELVE, which uses RNA sequencing to discern highly accurate treatment options for patient, and why the healthcare system needs an overhaul as it relates to cancer treatment. You may have heard our quick chat with David during the Sub 5 YouTube series around his athletic and miltiary background and the ultra running event on his vision board.

Marni On The Move Instagram, TikTok, LinkedIn, or YouTube`
Marni Salup on Instagram and Spotify

Sign up for our weekly newsletter, Do What Moves You, for Marni on the Move updates, exclusive offers, invites to events, and exciting news!

Shop InsideTracker for 20% Off

Leave us a review on Apple. It’s easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you’re listening to. Tell your friends to what you love on social. Screenshot or share directly from our stories the episode you’re listening to, tag us and the guests.